Hand transplants to be evaluated
Surgery team with VA, Emory will track outcomes
August 31, 2010
Hand transplants to be evaluated
Surgery team with VA, Emory will track outcomes
nly nine patients have ever received a
hand transplant in the U.S. It's a
staggeringly complex operation that can
take up to 16 hours—twice the time of the
average heart transplant. Surgeons must
painstakingly knit together nerves, tendons
and blood vessels—along with skin,
muscle, bone and cartilage—into a
seamless biological unit that looks just
like the patient's natural hand and works
almost as well.
The surgery is available at the Atlanta
VA Medical Center and its affiliate, Emory
University, as well as at a few elite centers
nationwide. The VA-Emory surgeon who
performs the procedure, Linda Cendales,
MD, is now looking to track outcomes
among patients through a new study
funded by VA, the Department of Defense
and other sources.
Who is eligible to take part in the
study? "Any upper-limb amputee, below
the elbow, who is between 18 and 55,"
says Cendales. "It doesn't matter how long
ago the amputation was—30 or 40 years,
or just a couple of months."
Hand transplant facts
Cendales has a rare combination of
skills: She is trained in hand and
microsurgery, as well as in transplant
surgery, which includes the
immunosuppression techniques that help
avoid rejection of a new limb. She took
part in the first two hand transplants that
were done in the U.S. A few months after
his 1999 transplant, the nation's first handtransplant
patient, Matthew Scott, from
New Jersey, used his new left hand to
throw out the ceremonial first pitch at the
Philadelphia Phillies' opening-day game.
"A limb transplant is an option to
recuperate a human hand," says Cendales.
"In my experience with hand transplantation, the patients report that the new
hand has been better for them than the
prostheses they were wearing."
She explains some of the advantages:
"It's a human hand, not a device. For many
people body image is important. The hand
recovers sensation and the patients are able
to perform activities such as turning
doorknobs, holding the newspaper, tying
their shoes. It's not a life-saving organ—it's
a quality-of-life transplant."
Cendales adds that some upper-limb
amputees prefer not dealing with the
potential inconveniences of prostheses:
"They need to take it off and put it on. If it's
myoelectric, they need to pay attention to
the weather changes." Also, she notes, a
person might need to change from one hand
prosthesis to another—each designed for a
different scope of activity—to do various
tasks.
At the same time, she points out that a
hand transplant is not the best option for
every upper-limb amputee. As with a liver
or kidney transplant, patients have to be on
anti-rejection drugs for as long as they have
the transplant. Side effects from medications
can include diarrhea, headache and
high blood pressure. Cendales notes that her
team minimizes the long-term use of some
of the drugs involved, such as steroids,
which can cause diabetes and other
problems.
The team approach also includes
evaluations to explore the potential
psychosocial impact of the procedure on
patients. Cendales says that to date, all those
who have received a hand transplant have
come to "consider the new hand as their
own, with no problems."
Cendales says she and other surgeons
value the role of other disciplines in
rehabilitating those who have lost limbs.
She acknowledges advances in upper-limb
prostheses—such as the DEKA arm, now
being tested by VA (see the May 2009 VA
Research Currents at www.research.va.gov/
currents)—and says such technology will
offer more options for amputees.
"Perhaps a good approach is the model
we follow," says Cendales. "We have a
multidisciplinary team that is patientcentered.
Our program aims to provide
another option for a selected group of
patients, and to provide the best options
overall for our amputees. If it's a prosthesis,
the best prosthesis, and if it's a hand, the
best-matched human hand."
This article originally appeared in the September 2010 issue of VA Research Currents.